Attenuated IP & The Call To Curtail Patent Rights During The Global Pandemic

As the global death toll from the coronavirus reached nearly three million, countries around the world raced to vaccinate their populations. The severity of the coronavirus crisis has led some to argue that products for the prevention and treatment of Covid-19 should be global public goods: unrestricted by intellectual property rights and free for all to use.

Citing the need for a more equitable distribution of vaccine doses, several countries have called on the World […]

By | May 14th, 2021 ||

Drafting Clearer Patent Claims After Federal Circuit L’Oreal Ruling

The U.S. Court of Appeals for the Federal Circuit recently highlighted an important rule of patent claim construction: that claim limitations should be construed in a way that avoids rendering claim terms meaningless or superfluous.

Claim terms are presumed to have their ordinary and accustomed meaning based on the plain language of the claim. However, claim interpretation can be more complicated when a claim limitation has more than one possible construction.

On March 4, in Olaplex […]

By | May 13th, 2021 ||

Considerations And Implications Of The Proposed Temporary Waiver Of COVID-19 Vaccine-Related Intellectual Property Rights

The Biden administration has indicated support for the temporary waiver of patent protections related to COVID-19 vaccine development.

In the United States, there are three COVID-19 vaccines that received emergency use authorization from the U.S. Food and Drug Administration. Millions of Americans are receiving vaccine dosages daily to inch the country closer toward herd immunity. Mass vaccination and achieving herd immunity would limit the ability of the virus to spread and develop further mutations that […]

By | May 11th, 2021 ||